Exercise is essential for managing diabetes and reducing the risk of heart disease. Regular physical activity helps combat ...

Third-quarter results for Medtronic (NYSE:MDT) included a timeline for a planned label expansion for its automated insulin ...

A new study led by researchers from Boston University Chobanian & Avedisian School of Medicine has found there is no consensus in how clinical experts interpret CGM reports from people without ...

DexCom , Inc. (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM) systems for diabetes management with a market capitalization of $34.8 billion, finds itself at a critical juncture as it ...

We recently published a list of the 10 Best Drug Stocks to Buy Now. In this article, we are going to take a look at where ...

One of the largest healthcare companies in India, Abbott sells a wide range of products, including medicines, nutrition, ...

Sales: The California-based device maker is pinning its hopes on Stelo, its recently launched device for adults aged 18 and older who do not use insulin, making it the first CGM available for over-the ...

These are the kinds of stocks long-term investors will often be interested in, since they must have excellent, resilient ...

Abbott Laboratories ABT faced industry-wide challenges that exerted pressure on its profit margins. Factors such as rising ...

A U.K. court has ruled against Abbott in a trademark infringement case the company had brought over the design of a rival ...

Sinocare announced recently that it successfully defended itself in court against trademark infringement claims brought by ...

We recently published a list of the 10 Best Medical Device Stocks To Buy According to Hedge Funds. In this article, we are ...